コンテンツへスキップ
Merck

1.04907

Supelco

Potassium bromide

for IR spectroscopy Uvasol®

別名:

Potassium bromide, Hydrobromic Acid Potassium Salt

ログイン組織・契約価格を表示する


About This Item

実験式(ヒル表記法):
BrK
CAS番号:
分子量:
119.00
MDL番号:
UNSPSCコード:
12352302
EC Index Number:
231-830-3
NACRES:
NA.03

蒸気圧

1.3 hPa ( 795 °C)

品質水準

形状

solid

有効性

>2000 mg/kg LD50, oral (Rat)

テクニック

IR spectroscopy: suitable

pH

5.5-8.5 (20 °C, 50 g/L in H2O)

bp

1435 °C/1013 hPa

mp

730 °C

溶解性

water: soluble (119 g/l at 20 °C (68 °F))

密度

2.75 g/cm3 at 20 °C

かさ密度

900‑1000 kg/m3

アプリケーション

general analytical

保管温度

2-30°C

SMILES記法

[K+].[Br-]

InChI

1S/BrH.K/h1H;/q;+1/p-1

InChI Key

IOLCXVTUBQKXJR-UHFFFAOYSA-M

詳細

Potassium bromide is transparent from the near UV to long wave IR wavelengths. In IR-spectroscopy, solid samples which are difficult to melt or dissolve in any suitable IR-transmitting solvent, are analyzed by grinding with Potassium bromide powder, and pressing into a disc. This procedure has a high quality demand of the used potassium bromide. Potassium bromide Uvasol is adjusted to a mean particle size of 150 μm. This is sufficient for the preparation of perfectly good pellets without the need for further pre-treatment and the associated risk of contamination. It also retains its powdery form over a period of years if stored in an air-tight condition. Its physical suitability for pelletising is checked by a special application test and its chemical purity established by full spectrum FT-IR analysis.

アプリケーション


  • A method for lipoprotein (a) Isolation from a small volume of plasma with applications for clinical research.: This study presents a method for isolating lipoprotein(a) using potassium bromide, which is significant for analytical applications in clinical research. The method′s precision enhances its potential utility in clinical diagnostics (Mueller et al., 2022).

  • Measurement uncertainty of lactase-containing tablets analyzed with FTIR.: This research evaluates the uncertainty in measuring lactase in tablets using Fourier Transform Infrared Spectroscopy (FTIR) with potassium bromide. The study highlights the compound′s importance in enhancing measurement accuracy in pharmaceutical analysis (Paakkunainen et al., 2014).

  • MCM-41-supported oxo-vanadium(IV) complex: a highly selective heterogeneous catalyst for the bromination of hydroxy aromatic compounds in water.: This study demonstrates the use of potassium bromide in synthesizing a heterogeneous catalyst, showcasing its application in selective bromination reactions, crucial for developing efficient chemical synthesis processes (Bhunia et al., 2011).

  • Proteomics and lipids of lipoproteins isolated at low salt concentrations in D2O/sucrose or in KBr.: The research investigates the proteomics and lipid profiles of lipoproteins isolated using potassium bromide, emphasizing its role in enhancing the resolution and accuracy of lipidomic studies in biochemistry (Ståhlman et al., 2008).

  • Single-drop and nanogram level determination of sulfite (SO3(2-)) in alcoholic and nonalcoholic beverage samples based on diffuse reflectance fourier transform infrared spectroscopic (DRS-FTIR) analysis on KBr matrix.: This article highlights the innovative use of potassium bromide in the analysis of sulfite levels in beverages, showcasing its utility in food and beverage quality control (Verma et al., 2007).

関連事項

Replaces: PX1378

アナリシスノート

Application test: passes test
Absorbance(2g pressed disk, 0.5 cm layer thickness)(Water; 3775-3050/1760-1520 cm⁻¹): ≤ 0.15
Absorbance(2g pressed disk, 0.5 cm layer thickness)(CH-compounds; 3050-2750 cm⁻¹): ≤ 0.004
Absorbance(2g pressed disk, 0.5 cm layer thickness)(other ; 4000-400 cm⁻¹): ≤ 0.020
Particle Size (d10): ≤ 100 µm
Particle Size (d50): ≤ 200 µm
Particle Size (d90): ≤ 500 µm

その他情報

Explore various lab safety accessories and equipment for safe handling of solvents to increase your safety level from the first usage.

法的情報

UVASOL is a registered trademark of Merck KGaA, Darmstadt, Germany

関連製品

製品番号
詳細
価格

ピクトグラム

Exclamation mark

シグナルワード

Warning

危険有害性情報

危険有害性の分類

Eye Irrit. 2

保管分類コード

13 - Non Combustible Solids

WGK

WGK 1

引火点(°F)

Not applicable

引火点(℃)

Not applicable


試験成績書(COA)

製品のロット番号・バッチ番号を入力して、試験成績書(COA) を検索できます。ロット番号・バッチ番号は、製品ラベルに「Lot」または「Batch」に続いて記載されています。

以前この製品を購入いただいたことがある場合

文書ライブラリで、最近購入した製品の文書を検索できます。

文書ライブラリにアクセスする

この製品を見ている人はこちらもチェック

Slide 1 of 3

1 of 3

プロトコル

Aripiprazole is an atypical antipsychotic and a partial dopamine agonist. It is primarily used in the treatment of schizophrenia, bipolar disorder, major depressive disorder, tic disorders, and irritability associated with autism. Aripiprazole was first approved by the U.S. Food and DrugAdministration in November 2002 for schizophrenia and by the European Medicines Agency in June 2004 for acute manic and mixed episodes associated with bipolar disorder.

ライフサイエンス、有機合成、材料科学、クロマトグラフィー、分析など、あらゆる分野の研究に経験のあるメンバーがおります。.

製品に関するお問い合わせはこちら(テクニカルサービス)